Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

Renin-angiotensin-aldosterone system (RAAS) blockade with angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II (Ang II), AT 1 receptor blockers (ARB) is the cornerstone of renoprotective therapy. Still, the number of patients with end-stage renal disease is increasing worldwide, prompt...

Full description

Bibliographic Details
Main Authors: Gozewijn D Laverman, Dick de Zeeuw, Gerjan Navis
Format: Article
Language:English
Published: SAGE Publications 2002-12-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2002.042

Similar Items

Similar Items